Probing molecular mechanism of inhibitor bindings to bromodomain-containing protein 4 based on molecular dynamics simulations and principal component analysis

References

• T. Kouzarides, Chromatin modifications and their function, Cell 128 (2007), pp. 693–705. doi:10.1016/j.cell.2007.02.005.
   PubMed Web of Science ®Google Scholar
• B.M. Turner, Reading signals on the nucleosome with a new nomenclature for modified histones, Nat. Struct. Mol. Biol. 12 (2005), pp. 110–112. doi:10.1038/nsmb0205-110.
   PubMed Web of Science ®Google Scholar
• K.J. Falkenberg and R.W. Johnstone, Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders, Nat. Rev. Drug Discov. 13 (2014), pp. 673–691.
   PubMed Web of Science ®Google Scholar
• J.W. Tamkun, R. Deuring, M.P. Scott, M. Kissinger, A.M. Pattatucci, T.C. Kaufman, and J.A. Kennison, Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF 2 SWI 2, Cell 68 (1992), pp. 561–572. doi:10.1016/0092-8674(92)90191-E.
   PubMed Web of Science ®Google Scholar
• S.R. Haynes, C. Dollard, F. Winston, S. Beck, J. Trowsdale, and I.B. Dawid, The bromodomain: A conserved sequence found in human, Drosophila and yeast proteins, Nucleic Acids Res. 20 (1992), pp. 2603–2603. doi:10.1093/nar/20.10.2603.
   PubMed Web of Science ®Google Scholar
• C. Arrowsmith, C. Bountra, P. Fish, K. Lee, and M. Schapira, Epigenetic protein families: A new frontier for drug discovery, Nat. Rev. Drug Discov. 11 (2012), pp. 384–400. doi:10.1038/nrd3674.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos, S. Picaud, M. Mangos, T. Keates, J.-P. Lambert, D. Barsyte-Lovejoy, I. Felletar, R. Volkmer, S. Müller, T. Pawson, A.-C. Gingras, C.H. Arrowsmith, and S. Knapp, Histone recognition and large-scale structural analysis of the human bromodomain family, Cell 149 (2012), pp. 214–231. doi:10.1016/j.cell.2012.02.013.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W.B. Smith, O. Fedorov, E.M. Morse, T. Keates, T.T. Hickman, I. Felletar, M. Philpott, S. Munro, M.R. McKeown, Y. Wang, A.L. Christie, N. West, M.J. Cameron, B. Schwartz, T.D. Heightman, N. La Thangue, C.A. French, O. Wiest, A.L. Kung, S. Knapp, and J.E. Bradner, Selective inhibition of BET bromodomains, Nature 468 (2010), pp. 1067–1073. doi:10.1038/nature09504.
   PubMed Web of Science ®Google Scholar
• D.J. Owen, P. Ornaghi, J.C. Yang, N. Lowe, P.R. Evans, P. Ballario, D. Neuhaus, P. Filetici, and A.A. Travers, The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p, Embo J. 19 (2000), pp. 6141–6149. doi:10.1093/emboj/19.22.6141.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos and S. Knapp, The bromodomain interaction module, FEBS Lett. 586 (2012), pp. 2692–2704. doi:10.1016/j.febslet.2012.04.045.
   PubMed Web of Science ®Google Scholar
• A. Dey, J. Ellenberg, A. Farina, A.E. Coleman, T. Maruyama, S. Sciortino, J. Lippincott-Schwartz, and K. Ozato, A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G2-to-M transition, Mol. Cell. Biol. 20 (2000), pp. 6537–6549. doi:10.1128/MCB.20.17.6537-6549.2000.
   PubMed Web of Science ®Google Scholar
• B.N. Devaiah, B.A. Lewis, N. Cherman, M.C. Hewitt, B.K. Albrecht, P.G. Robey, K. Ozato, R.J. Sims, and D.S. Singer, BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain, Proc. Natl. Acad. Sci. U. S. A. 109 (2012), pp. 6927–6932. doi:10.1073/pnas.1120422109.
   PubMed Web of Science ®Google Scholar
• C. Dhalluin, J.E. Carlson, L. Zeng, C. He, A.K. Aggarwal, M.-M. Zhou, and M.-M. Zhou, Structure and ligand of a histone acetyltransferase bromodomain, Nature 399 (1999), pp. 491–496. doi:10.1038/20974.
   PubMed Web of Science ®Google Scholar
• L. Zeng and M.-M. Zhou, Bromodomain: An acetyl-lysine binding domain, FEBS Lett. 513 (2002), pp. 124–128. doi:10.1016/S0014-5793(01)03309-9.
   PubMed Web of Science ®Google Scholar
• R. Chen, J.H.N. Yik, Q.J. Lew, and S.-H. Chao, Brd4 and HEXIM1: Multiple roles in P-TEFb regulation and cancer, Biomed. Res. Int. 2014 (2014), pp. 232870–232870. doi:10.1155/2014/232870.
   PubMed Web of Science ®Google Scholar
• Z. Cheng, Y. Gong, Y. Ma, K. Lu, X. Lu, L.A. Pierce, R.C. Thompson, S. Muller, S. Knapp, and J. Wang, Inhibition of BET bromodomain targets genetically diverse glioblastoma, Clin. Cancer Res. 19 (2013), pp. 1748–1759. doi:10.1158/1078-0432.CCR-12-3066.
   PubMed Web of Science ®Google Scholar
• J. Wang and Z. Cheng, Abstract 1018: Inhibition of BET bromodomain targets genetically diverse glioblastoma, Cancer Res. 73 (2013), pp. 1018–1018.
   Google Scholar
• M. Jung, M. Philpott, S. Muller, J. Schulze, V. Badock, U. Eberspacher, D. Moosmayer, B. Bader, N. Schmees, A. Fernandez-Montalvan, and B. Haendler, Affinity map of bromodomain protein 4 (BRD4), interactions with the histone H4 tail and the small molecule inhibitor JQ1, J. Biol. Chem. 289 (2014), pp. 9304–9319. doi:10.1074/jbc.M113.523019.
   PubMed Web of Science ®Google Scholar
• M.K. Jang, K. Mochizuki, M. Zhou, H.S. Jeong, J.N. Brady, and K. Ozato, The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription, Mol. Cell 19 (2005), pp. 523–534. doi:10.1016/j.molcel.2005.06.027.
   PubMed Web of Science ®Google Scholar
• Z. Yang, J.H. Yik, R. Chen, N. He, M.K. Jang, K. Ozato, and Q. Zhou, Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4, Mol. Cell 19 (2005), pp. 535–545. doi:10.1016/j.molcel.2005.06.029.
   PubMed Web of Science ®Google Scholar
• Z. Yang, N. He, and Q. Zhou, Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression, Mol. Cell. Biol. 28 (2008), pp. 967–976. doi:10.1128/MCB.01020-07.
   PubMed Web of Science ®Google Scholar
• K. Mochizuki, A. Nishiyama, M.K. Jang, A. Dey, A. Ghosh, T. Tamura, H. Natsume, H. Yao, and K. Ozato, The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase, J. Biol. Chem. 283 (2008), pp. 9040–9048. doi:10.1074/jbc.M707603200.
   PubMed Web of Science ®Google Scholar
• J. Bhadury, L.M. Nilsson, S.V. Muralidharan, L.C. Green, Z. Li, E.M. Gesner, H.C. Hansen, U.B. Keller, K.G. McLure, and J.A. Nilsson, BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma, Proc. Natl. Acad. Sci. U. S. A. 111 (2014), pp. E2721–2730. doi:10.1073/pnas.1406722111.
   PubMed Web of Science ®Google Scholar
• M.A. Dawson, E.J. Gudgin, S.J. Horton, G. Giotopoulos, E. Meduri, S. Robson, E. Cannizzaro, H. Osaki, M. Wiese, S. Putwain, C.Y. Fong, C. Grove, J. Craig, A. Dittmann, D. Lugo, P. Jeffrey, G. Drewes, K. Lee, L. Bullinger, R.K. Prinjha, T. Kouzarides, G.S. Vassiliou, and B.J.P. Huntly, Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia, Leukemia 28 (2014), pp. 311–320. doi:10.1038/leu.2013.338.
   PubMed Web of Science ®Google Scholar
• M. Hussong, S.T. Borno, M. Kerick, A. Wunderlich, A. Franz, H. Sultmann, B. Timmermann, H. Lehrach, M. Hirsch-Kauffmann, and M.R. Schweiger, The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response, Cell Death Dis. 5 (2014), pp. e1195. doi:10.1038/cddis.2014.157.
   PubMed Web of Science ®Google Scholar
• W.W. Lockwood, K. Zejnullahu, J.E. Bradner, and H. Varmus, Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins, Proc. Natl. Acad. Sci. U. S. A. 109 (2012), pp. 19408–19413. doi:10.1073/pnas.1216363109.
   PubMed Web of Science ®Google Scholar
• Y. Tang, S. Gholamin, S. Schubert, M.I. Willardson, A. Lee, P. Bandopadhayay, G. Bergthold, S. Masoud, B. Nguyen, N. Vue, B. Balansay, F. Yu, S. Oh, P. Woo, S. Chen, A. Ponnuswami, M. Monje, S.X. Atwood, R.J. Whitson, S. Mitra, S.H. Cheshier, J. Qi, R. Beroukhim, J.Y. Tang, R. Wechsler-Reya, A.E. Oro, B.A. Link, J.E. Bradner, and Y.-J. Cho, Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition, Nat. Med. 20 (2014), pp. 732–740. doi:10.1038/nm.3613.
   PubMed Web of Science ®Google Scholar
• J. Zuber, J. Shi, E. Wang, A.R. Rappaport, H. Herrmann, E.A. Sison, D. Magoon, J. Qi, K. Blatt, M. Wunderlich, M.J. Taylor, C. Johns, A. Chicas, J.C. Mulloy, S.C. Kogan, P. Brown, P. Valent, J.E. Bradner, S.W. Lowe, and C.R. Vakoc, RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Nature 478 (2011), pp. 524–528. doi:10.1038/nature10334.
   PubMed Web of Science ®Google Scholar
• F. Lamoureux, M. Baud’huin, L. Rodriguez Calleja, C. Jacques, M. Berreur, F. Redini, F. Lecanda, J.E. Bradner, D. Heymann, and B. Ory, Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle, Nat. Commun. 5 (2014), pp. 3511. doi:10.1038/ncomms4511.
   PubMed Web of Science ®Google Scholar
• X. Gao, X. Wu, X. Zhang, W. Hua, Y. Zhang, Y. Maimaiti, Z. Gao, and Y. Zhang, Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer, Biochem. Biophys. Res. Commun. 469 (2016), pp. 679–685. doi:10.1016/j.bbrc.2015.12.008.
   PubMed Web of Science ®Google Scholar
• D.S. Hewings, M. Wang, M. Philpott, O. Fedorov, S. Uttarkar, P. Filippakopoulos, S. Picaud, C. Vuppusetty, B. Marsden, S. Knapp, S.J. Conway, and T.D. Heightman, 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands, J. Med. Chem. 54 (2011), pp. 6761–6770. doi:10.1021/jm200640v.
   PubMed Web of Science ®Google Scholar
• X. Lucas, D. Wohlwend, M. Hugle, K. Schmidtkunz, S. Gerhardt, R. Schule, M. Jung, O. Einsle, and S. Gunther, 4-Acyl pyrroles: Mimicking acetylated lysines in histone code reading, Angew. Chem. Int. Ed. 52 (2013), pp. 14055–14059. doi:10.1002/anie.201307652.
   PubMed Web of Science ®Google Scholar
• M.A. Dawson, R.K. Prinjha, A. Dittmann, G. Giotopoulos, M. Bantscheff, W.I. Chan, S.C. Robson, C.W. Chung, C. Hopf, M.M. Savitski, C. Huthmacher, E. Gudgin, D. Lugo, S. Beinke, T.D. Chapman, E.J. Roberts, P.E. Soden, K.R. Auger, O. Mirguet, K. Doehner, R. Delwel, A.K. Burnett, P. Jeffrey, G. Drewes, K. Lee, B.J. Huntly, and T. Kouzarides, Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia, Nature 478 (2011), pp. 529–533. doi:10.1038/nature10509.
   PubMed Web of Science ®Google Scholar
• G. Zhang, A.N. Plotnikov, E. Rusinova, T. Shen, K. Morohashi, J. Joshua, L. Zeng, S. Mujtaba, M. Ohlmeyer, and M.M. Zhou, Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains, J. Med. Chem. 56 (2013), pp. 9251–9264. doi:10.1021/jm401334s.
   PubMed Web of Science ®Google Scholar
• E. Nicodeme, K.L. Jeffrey, U. Schaefer, S. Beinke, S. Dewell, C.W. Chung, R. Chandwani, I. Marazzi, P. Wilson, H. Coste, J. White, J. Kirilovsky, C.M. Rice, J.M. Lora, R.K. Prinjha, K. Lee, and A. Tarakhovsky, Suppression of inflammation by a synthetic histone mimic, Nature 468 (2010), pp. 1119–1123. doi:10.1038/nature09589.
   PubMed Web of Science ®Google Scholar
• M. Boi, M. Todaro, V. Vurchio, E. Cvitkovic, M. Riveiro, F. Bertoni, and G. Inghirami, Abstract A219: OTX015, a bromodomain and extraterminal inhibitor, represents a novel agent for ALK positive anaplastic large cell lymphoma, Mol. Cancer Ther. 12 (2014), pp. A219–A219.
   Web of Science ®Google Scholar
• S. Picaud, C. Wells, I. Felletar, D. Brotherton, S. Martin, P. Savitsky, B. Diez-Dacal, M. Philpott, C. Bountra, H. Lingard, O. Fedorov, S. Muller, P.E. Brennan, S. Knapp, and P. Filippakopoulos, RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain, Proc. Natl. Acad. Sci. U. S. A. 110 (2013), pp. 19754–19759. doi:10.1073/pnas.1310658110.
   PubMed Web of Science ®Google Scholar
• J.M. Garnier, P.P. Sharp, and C.J. Burns, BET bromodomain inhibitors: A patent review, Expert. Opin. Ther. Pat. 24 (2014), pp. 185–199. doi:10.1517/13543776.2014.859244.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos and S. Knapp, Targeting bromodomains: Epigenetic readers of lysine acetylation, Nat. Rev. Drug Discov. 13 (2014), pp. 337–356. doi:10.1038/nrd4286.
   PubMed Web of Science ®Google Scholar
• L.L. Duan, G.Q. Feng, and Q.G. Zhang, Large-scale molecular dynamics simulation: Effect of polarization on thrombin-ligand binding energy, Sci. Rep. 6 (2016), pp. 31488. doi:10.1038/srep31488.
   PubMedGoogle Scholar
• G. Hu, Z. Cao, S. Xu, W. Wang, and J. Wang, Revealing the binding modes and the unbinding of 14-3-3σ proteins and inhibitors by computational methods, Sci. Rep. 5 (2015), pp. 16481–16481. doi:10.1038/srep16481.
   PubMed Web of Science ®Google Scholar
• G. Li, H. Shen, D. Zhang, Y. Li, and H. Wang, Coarse-grained modeling of nucleic acids using anisotropic gay-berne and electric multipole potentials, J. Chem. Theory Comput. 12 (2016), pp. 676–693. doi:10.1021/acs.jctc.5b00903.
   PubMed Web of Science ®Google Scholar
• M.A. Azam, S. Jupudi, N. Saha, and R.K. Paul, Combining molecular docking and molecular dynamics studies for modelling Staphylococcus aureus MurD inhibitory activity, SAR QSAR Environ. Res. 30 (2019), pp. 1–20. doi:10.1080/1062936X.2018.1539034.
   PubMed Web of Science ®Google Scholar
• P. Kamsri, A. Punkvang, S. Hannongbua, K. Suttisintong, P. Kittakoop, J. Spencer, A.J. Mulholland, and P. Pungpo, In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations, SAR QSAR Environ. Res. 30 (2019), pp. 775–800. doi:10.1080/1062936X.2019.1658218.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, B. Yin, L. Pang, W. Wang, and W. Zhu, Molecular mechanism of binding selectivity of inhibitors toward BACE1 and BACE2 revealed by multiple short molecular dynamics simulations and free-energy predictions, ACS Chem. Neurosci. 10 (2019), pp. 4303–4318. doi:10.1021/acschemneuro.9b00348.
   PubMed Web of Science ®Google Scholar
• J. Zhao, B. Yin, H. Sun, L. Pang, and J. Chen, Identifying hot spots of inhibitor-CDK2 bindings by computational alanine scanning, Chem. Phys. Lett. 747 (2020), pp. 137329. doi:10.1016/j.cplett.2020.137329.
   Web of Science ®Google Scholar
• J. Chen, Z. Liang, W. Wang, C. Yi, S. Zhang, and Q. Zhang, Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations, Sci. Rep. 4 (2014), pp. 6872.
   PubMed Web of Science ®Google Scholar
• F. Yan, X. Liu, S. Zhang, J. Su, Q. Zhang, and J. Chen, Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations, J. Biomol. Struct. Dyn. 36 (2018), pp. 3636–3650. doi:10.1080/07391102.2017.1394221.
   PubMed Web of Science ®Google Scholar
• S. Majumdar, S.C. Basak, C.N. Lungu, M.V. Diudea, and G.D. Grunwald, Mathematical structural descriptors and mutagenicity assessment: A study with congeneric and diverse datasets, SAR QSAR Environ. Res. 29 (2018), pp. 579–590. doi:10.1080/1062936X.2018.1496475.
   PubMed Web of Science ®Google Scholar
• J. Wang, Q. Shao, B.P. Cossins, J. Shi, K. Chen, and W. Zhu, Thermodynamics calculation of protein-ligand interactions by QM/MM polarizable charge parameters, J. Biomol. Struct. Dyn. 34 (2016), pp. 163–176. doi:10.1080/07391102.2015.1019928.
   PubMed Web of Science ®Google Scholar
• X. Jia, M. Wang, Y. Shao, G. Konig, B.R. Brooks, J.Z. Zhang, and Y. Mei, Calculations of solvation free energy through energy reweighting from molecular mechanics to quantum mechanics, J. Chem. Theory Comput. 12 (2016), pp. 499–511. doi:10.1021/acs.jctc.5b00920.
   PubMed Web of Science ®Google Scholar
• E.L. Wu, Y. Mei, K. Han, and J.Z. Zhang, Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human alpha-thrombin, Biophys. J. 92 (2007), pp. 4244–4253. doi:10.1529/biophysj.106.099150.
   PubMed Web of Science ®Google Scholar
• T. Hou, J. Wang, Y. Li, and W. Wang, Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations, J. Chem. Inf. Model. 51 (2011), pp. 69–82. doi:10.1021/ci100275a.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, T. Zhu, Q. Zhang, and J.Z. Zhang, A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 protease based on thermodynamic integration and MM-PBSA methods, J. Chem. Inf. Model. 55 (2015), pp. 1903–1913. doi:10.1021/acs.jcim.5b00173.
   PubMed Web of Science ®Google Scholar
• U. Raj, H. Kumar, and P.K. Varadwaj, Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors, J. Biomol. Struct. Dyn. 35 (2017), pp. 2351–2362. doi:10.1080/07391102.2016.1217276.
   PubMed Web of Science ®Google Scholar
• K.K. Kumar, B.U. Devi, and P. Neeraja, Molecular activities and ligand-binding specificities of StAR-related lipid transfer domains: Exploring integrated in silico methods and ensemble-docking approaches, SAR QSAR Environ. Res. 29 (2018), pp. 483–501. doi:10.1080/1062936X.2018.1462847.
   PubMed Web of Science ®Google Scholar
• S. Bhuvaneshwari and K. Sankaranarayanan, Identification of potential CRAC channel inhibitors: Pharmacophore mapping, 3D-QSAR modelling, and molecular docking approach, SAR QSAR Environ. Res. 30 (2019), pp. 81–108. doi:10.1080/1062936X.2019.1566172.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, L. Pang, J.Z.H. Zhang, and T. Zhu, Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations, Nucleic Acids Res. 47 (2019), pp. 6618–6631. doi:10.1093/nar/gkz499.
   PubMed Web of Science ®Google Scholar
• M. Kuang, J. Zhou, L. Wang, Z. Liu, J. Guo, and R. Wu, Binding kinetics versus affinities in BRD4 inhibition, J. Chem. Inf. Model. 55 (2015), pp. 1926–1935. doi:10.1021/acs.jcim.5b00265.
   PubMed Web of Science ®Google Scholar
• R. Tumdam, A. Kumar, N. Subbarao, and B.S. Balaji, In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1, SAR QSAR Environ. Res. 29 (2018), pp. 975–996. doi:10.1080/1062936X.2018.1537301.
   PubMed Web of Science ®Google Scholar
• C. Muvva, E.R. Singam, S.S. Raman, and V. Subramanian, Structure-based virtual screening of novel, high-affinity BRD4 inhibitors, Mol. Biosyst. 10 (2014), pp. 2384–2397. doi:10.1039/C4MB00243A.
   PubMedGoogle Scholar
• Y. Wang, L.F. Wang, L.L. Zhang, H.B. Sun, and J. Zhao, Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies, SAR QSAR Environ. Res. 31 (2020), pp. 149–170. doi:10.1080/1062936X.2019.1701075.
   PubMed Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations, J. Biomol. Struct. Dyn. 36 (2018), pp. 1212–1224. doi:10.1080/07391102.2017.1317666.
   PubMed Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations, Chem. Biol. Drug Des. 93 (2019), pp. 163–176. doi:10.1111/cbdd.13398.
   PubMed Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations, Chem. Biol. Drug Des. 91 (2018), pp. 828–840. doi:10.1111/cbdd.13148.
   PubMed Web of Science ®Google Scholar
• L. Wang, Y. Wang, H. Sun, J. Zhao, and Q. Wang, Theoretical insight into molecular mechanisms of inhibitor bindings to bromodomain-containing protein 4 using molecular dynamics simulations and calculations of binding free energies, Chem. Phys. Lett. 736 (2019), pp. 136785. doi:10.1016/j.cplett.2019.136785.
   Web of Science ®Google Scholar
• M. Zhang, Y. Zhang, M. Song, X. Xue, J. Wang, C. Wang, C. Zhang, C. Li, Q. Xiang, L. Zou, X. Wu, C. Wu, B. Dong, W. Xue, Y. Zhou, H. Chen, D. Wu, K. Ding, and Y. Xu, Structure-based discovery and optimization of benzo[d]isoxazole derivatives as potent and selective bet inhibitors for potential treatment of castration-resistant prostate cancer (CRPC), J. Med. Chem. 61 (2018), pp. 3037–3058. doi:10.1021/acs.jmedchem.8b00103.
   PubMed Web of Science ®Google Scholar
• M. Amaral, D.B. Kokh, J. Bomke, A. Wegener, H.P. Buchstaller, H.M. Eggenweiler, P. Matias, C. Sirrenberg, R.C. Wade, and M. Frech, Protein conformational flexibility modulates kinetics and thermodynamics of drug binding, Nat. Commun. 8 (2017), pp. 2276. doi:10.1038/s41467-017-02258-w.
   PubMed Web of Science ®Google Scholar
• D.L. Penkler, C. Atilgan, and Ö. Tastan Bishop, Allosteric modulation of human Hsp90α conformational dynamics, J. Chem. Inf. Model. 58 (2018), pp. 383–404. doi:10.1021/acs.jcim.7b00630.
   PubMed Web of Science ®Google Scholar
• D.A. Case, T.E. Cheatham 3rd, T. Darden, H. Gohlke, R. Luo, K.M. Merz Jr., A. Onufriev, C. Simmerling, B. Wang, and R.J. Woods, The Amber biomolecular simulation programs, J. Comput. Chem. 26 (2005), pp. 1668–1688. doi:10.1002/jcc.20290.
   PubMed Web of Science ®Google Scholar
• D.C. Bas, D.M. Rogers, and J.H. Jensen, Very fast prediction and rationalization of pKa values for protein-ligand complexes, Proteins 73 (2008), pp. 765–783. doi:10.1002/prot.22102.
   PubMed Web of Science ®Google Scholar
• H. Li, A.D. Robertson, and J.H. Jensen, Very fast empirical prediction and rationalization of protein pKa values, Proteins 61 (2005), pp. 704–721. doi:10.1002/prot.20660.
   PubMed Web of Science ®Google Scholar
• A. Jakalian, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comput. Chem. 23 (2002), pp. 1623–1641. doi:10.1002/jcc.10128.
   PubMed Web of Science ®Google Scholar
• A. Jakalian, B. Bush, D. Jack, and C. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method, J. Comput. Chem. 21 (2000), pp. 132–146. doi:10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P.
   Web of Science ®Google Scholar
• J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:10.1021/acs.jctc.5b00255.
   PubMed Web of Science ®Google Scholar
• W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935. doi:10.1063/1.445869.
   Web of Science ®Google Scholar
• J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:10.1002/jcc.20035.
   PubMed Web of Science ®Google Scholar
• R. Salomon-Ferrer, A.W. Götz, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald, J. Chem. Theory Comput. 9 (2013), pp. 3878–3888. doi:10.1021/ct400314y.
   PubMed Web of Science ®Google Scholar
• T.G. Coleman, H.C. Mesick, and R.L. Darby, Numerical integration: A method for improving solution stability in models of the circulation, Ann. Biomed. Eng. 5 (1977), pp. 322–328. doi:10.1007/BF02367312.
   PubMed Web of Science ®Google Scholar
• J.A. Izaguirre, D.P. Catarello, J.M. Wozniak, and R.D. Skeel, Langevin stabilization of molecular dynamics, J. Chem. Phys. 114 (2001), pp. 2090–2098. doi:10.1063/1.1332996.
   Web of Science ®Google Scholar
• U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995), pp. 8577–8593. doi:10.1063/1.470117.
   Web of Science ®Google Scholar
• C. Suri and P.K. Naik, Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA), to predict noscapinoid binding to γ-tubulin dimer, SAR QSAR Environ. Res. 26 (2015), pp. 507–519. doi:10.1080/1062936X.2015.1070200.
   PubMed Web of Science ®Google Scholar
• W. Wang and P.A. Kollman, Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model. J. Mol. Biol. 303 (2000), pp. 567–582. doi:10.1006/jmbi.2000.4057.
   PubMed Web of Science ®Google Scholar
• W. Wang and P.A. Kollman, Computational study of protein specificity: The molecular basis of HIV-1 protease drug resistance, Proc. Natl. Acad. Sci. U. S. A. 98 (2001), pp. 14937–14942. doi:10.1073/pnas.251265598.
   PubMed Web of Science ®Google Scholar
• J. Wang, P. Morin, W. Wang, and P.A. Kollman, Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA, J. Am. Chem. Soc. 123 (2001), pp. 5221–5230. doi:10.1021/ja003834q.
   PubMed Web of Science ®Google Scholar
• C. Wang, D.A. Greene, L. Xiao, R. Qi, and R. Luo, Recent developments and applications of the MMPBSA method, Front. Mol. Biosci. 4 (2018), pp. 1–18.
   Web of Science ®Google Scholar
• H. Sun, Y. Li, M. Shen, S. Tian, L. Xu, P. Pan, Y. Guan, and T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring, Phys. Chem. Chem. Phys. 16 (2014), pp. 22035–22045. doi:10.1039/C4CP03179B.
   PubMed Web of Science ®Google Scholar
• H. Sun, Y. Li, S. Tian, L. Xu, and T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set, Phys. Chem. Chem. Phys. 16 (2014), pp. 16719–16729. doi:10.1039/C4CP01388C.
   PubMed Web of Science ®Google Scholar
• S. Tian, J. Zeng, X. Liu, J. Chen, J.Z.H. Zhang, and T. Zhu, Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling, Phys. Chem. Chem. Phys. 21 (2019), pp. 22103–22112. doi:10.1039/C9CP03598B.
   PubMed Web of Science ®Google Scholar
• B.R. Miller, T.D. McGee, J.M. Swails, N. Homeyer, H. Gohlke, and A.E. Roitberg, MMPBSA.py: An efficient program for end-state free energy calculations, J. Chem. Theory Comput. 8 (2012), pp. 3314–3321. doi:10.1021/ct300418h.
   PubMed Web of Science ®Google Scholar
• W. Cheng, J. Chen, Z. Liang, G. Li, C. Yi, W. Wang, and K. Wang, A computational analysis of interaction mechanisms of peptide and non-peptide inhibitors with MDMX based on molecular dynamics simulation, Comput. Theor. Chem. 984 (2012), pp. 43–50. doi:10.1016/j.comptc.2012.01.010.
   Web of Science ®Google Scholar
• T. Ichiye and M. Karplus, Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations, Proteins 11 (1991), pp. 205–217. doi:10.1002/prot.340110305.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Liu, S. Zhang, J. Chen, H. Sun, L. Zhang, and Q. Zhang, Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses, Phys. Chem. Chem. Phys. 22 (2020), pp. 2262–2275. doi:10.1039/C9CP05704H.
   PubMed Web of Science ®Google Scholar
• Y. Gao, T. Zhu, and J. Chen, Exploring drug-resistant mechanisms of I84V mutation in HIV-1 protease toward different inhibitors by thermodynamics integration and solvated interaction energy method, Chem. Phys. Lett. 706 (2018), pp. 400–408. doi:10.1016/j.cplett.2018.06.040.
   Web of Science ®Google Scholar
• J. Chen, L. Pang, W. Wang, L. Wang, J.Z.H. Zhang, and T. Zhu, Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations, J. Biomol. Struct. Dyn. 38 (2020), pp. 985–996. doi:10.1080/07391102.2019.1591304.
   PubMed Web of Science ®Google Scholar
• D.R. Roe and T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095. doi:10.1021/ct400341p.
   PubMed Web of Science ®Google Scholar
• R.M. Levy, A.R. Srinivasan, W.K. Olson, and J.A. McCammon, Quasi-harmonic method for studying very low frequency modes in proteins, Biopolymers 23 (1984), pp. 1099–1112. doi:10.1002/bip.360230610.
   PubMed Web of Science ®Google Scholar
• A. Amadei, A.B.M. Linssen, and H.J.C. Berendsen, Essential dynamics of proteins, Proteins 17 (1993), pp. 412–425. doi:10.1002/prot.340170408.
   PubMed Web of Science ®Google Scholar
• M. Laberge and T. Yonetani, Molecular dynamics simulations of hemoglobin a in different states and bound to DPG: Effector-linked perturbation of tertiary conformations and HbA concerted dynamics, Biophys. J. 94 (2008), pp. 2737–2751. doi:10.1529/biophysj.107.114942.
   PubMed Web of Science ®Google Scholar
• W. Humphrey, A. Dalke, and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph. 14 (1996), pp. 33–38. doi:10.1016/0263-7855(96)00018-5.
   PubMed Web of Science ®Google Scholar